Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Ablation of tau causes an olfactory deficit in a murine model of Parkinson's disease.

Beauchamp LC, Chan J, Hung LW, Padman BS, Vella LJ, Liu XM, Coleman B, Bush AI, Lazarou M, Hill AF, Jacobson L, Barnham KJ.

Acta Neuropathol Commun. 2018 Jul 5;6(1):57. doi: 10.1186/s40478-018-0560-y.

2.

Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.

Yap T, Koo K, Cheng L, Vella LJ, Hill AF, Reynolds E, Nastri A, Cirillo N, Seers C, McCullough M.

Cancer Prev Res (Phila). 2018 Aug;11(8):491-502. doi: 10.1158/1940-6207.CAPR-17-0409. Epub 2018 May 15.

PMID:
29764807
3.

Amyloid Precursor Protein Dimerisation Reduces Neurite Outgrowth.

Luu L, Ciccotosto GD, Vella LJ, Cheng L, Roisman LC, Multhaup G, Hill AF, Munter LM, Cappai R.

Mol Neurobiol. 2018 Apr 19. doi: 10.1007/s12035-018-1070-4. [Epub ahead of print]

PMID:
29675574
4.

Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle-Associated PDGFRβ.

Vella LJ, Behren A, Coleman B, Greening DW, Hill AF, Cebon J.

Neoplasia. 2017 Nov;19(11):932-940. doi: 10.1016/j.neo.2017.07.002. Epub 2017 Sep 28.

5.

Generation of Infectious Prions and Detection with the Prion-Infected Cell Assay.

Vella LJ, Coleman B, Hill AF.

Methods Mol Biol. 2017;1658:105-118. doi: 10.1007/978-1-4939-7244-9_9.

PMID:
28861786
6.

A rigorous method to enrich for exosomes from brain tissue.

Vella LJ, Scicluna BJ, Cheng L, Bawden EG, Masters CL, Ang CS, Willamson N, McLean C, Barnham KJ, Hill AF.

J Extracell Vesicles. 2017 Jul 26;6(1):1348885. doi: 10.1080/20013078.2017.1348885. eCollection 2017.

7.

Oral swirl samples - a robust source of microRNA protected by extracellular vesicles.

Yap T, Vella LJ, Seers C, Nastri A, Reynolds E, Cirillo N, McCullough M.

Oral Dis. 2017 Apr;23(3):312-317. doi: 10.1111/odi.12603. Epub 2016 Dec 23.

PMID:
27796067
8.
9.

The contribution of tumour-derived exosomes to the hallmarks of cancer.

Meehan K, Vella LJ.

Crit Rev Clin Lab Sci. 2016;53(2):121-31. doi: 10.3109/10408363.2015.1092496. Epub 2015 Oct 19. Review.

PMID:
26479834
10.

Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma.

Parker R, Vella LJ, Xavier D, Amirkhani A, Parker J, Cebon J, Molloy MP.

Front Oncol. 2015 May 15;5:95. doi: 10.3389/fonc.2015.00095. eCollection 2015.

11.

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.

Vella LJ, Andrews MC, Pasam A, Woods K, Behren A, Cebon JS.

Oncoimmunology. 2014 Jul 3;3(7):e946367. eCollection 2014.

12.

The emerging role of exosomes in epithelial-mesenchymal-transition in cancer.

Vella LJ.

Front Oncol. 2014 Dec 19;4:361. doi: 10.3389/fonc.2014.00361. eCollection 2014. Review.

13.

EVpedia: a community web portal for extracellular vesicles research.

Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, Kim JH, Go G, Nhung D, Hong K, Jang SC, Kim SH, Park KS, Kim OY, Park HT, Seo JH, Aikawa E, Baj-Krzyworzeka M, van Balkom BW, Belting M, Blanc L, Bond V, Bongiovanni A, Borràs FE, Buée L, Buzás EI, Cheng L, Clayton A, Cocucci E, Dela Cruz CS, Desiderio DM, Di Vizio D, Ekström K, Falcon-Perez JM, Gardiner C, Giebel B, Greening DW, Gross JC, Gupta D, Hendrix A, Hill AF, Hill MM, Nolte-'t Hoen E, Hwang DW, Inal J, Jagannadham MV, Jayachandran M, Jee YK, Jørgensen M, Kim KP, Kim YK, Kislinger T, Lässer C, Lee DS, Lee H, van Leeuwen J, Lener T, Liu ML, Lötvall J, Marcilla A, Mathivanan S, Möller A, Morhayim J, Mullier F, Nazarenko I, Nieuwland R, Nunes DN, Pang K, Park J, Patel T, Pocsfalvi G, Del Portillo H, Putz U, Ramirez MI, Rodrigues ML, Roh TY, Royo F, Sahoo S, Schiffelers R, Sharma S, Siljander P, Simpson RJ, Soekmadji C, Stahl P, Stensballe A, Stępień E, Tahara H, Trummer A, Valadi H, Vella LJ, Wai SN, Witwer K, Yáñez-Mó M, Youn H, Zeidler R, Gho YS.

Bioinformatics. 2015 Mar 15;31(6):933-9. doi: 10.1093/bioinformatics/btu741. Epub 2014 Nov 10.

14.

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma.

Jayachandran A, Anaka M, Prithviraj P, Hudson C, McKeown SJ, Lo PH, Vella LJ, Goding CR, Cebon J, Behren A.

Oncotarget. 2014 Jul 30;5(14):5782-97.

15.

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

Vella LJ, Andrews MC, Behren A, Cebon J, Woods K.

Expert Rev Clin Immunol. 2014 Aug;10(8):1107-23. doi: 10.1586/1744666X.2014.929943. Epub 2014 Jun 17. Review.

PMID:
24939732
16.

MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells.

Vella LJ, Pasam A, Dimopoulos N, Andrews M, Knights A, Puaux AL, Louahed J, Chen W, Woods K, Cebon JS.

Cancer Immunol Res. 2014 Apr;2(4):351-60. doi: 10.1158/2326-6066.CIR-13-0181. Epub 2014 Jan 17.

17.

BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.

Andrews MC, Behren A, Chionh F, Mariadason J, Vella LJ, Do H, Dobrovic A, Tebbutt N, Cebon J.

J Clin Oncol. 2013 Dec 10;31(35):e448-51. doi: 10.1200/JCO.2013.50.4118. Epub 2013 Nov 4. No abstract available.

PMID:
24190114
18.

The Ludwig institute for cancer research Melbourne melanoma cell line panel.

Behren A, Anaka M, Lo PH, Vella LJ, Davis ID, Catimel J, Cardwell T, Gedye C, Hudson C, Stan R, Cebon J.

Pigment Cell Melanoma Res. 2013 Jul;26(4):597-600. doi: 10.1111/pcmr.12097. Epub 2013 Apr 11. No abstract available.

PMID:
23527996
19.

The amyloid precursor protein copper binding domain histidine residues 149 and 151 mediate APP stability and metabolism.

Spoerri L, Vella LJ, Pham CL, Barnham KJ, Cappai R.

J Biol Chem. 2012 Aug 3;287(32):26840-53. doi: 10.1074/jbc.M112.355743. Epub 2012 Jun 8.

20.

Identification of a novel amyloid precursor protein processing pathway that generates secreted N-terminal fragments.

Vella LJ, Cappai R.

FASEB J. 2012 Jul;26(7):2930-40. doi: 10.1096/fj.11-200295. Epub 2012 Apr 6.

PMID:
22490781
21.

C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress.

Meyerowitz J, Parker SJ, Vella LJ, Ng DCh, Price KA, Liddell JR, Caragounis A, Li QX, Masters CL, Nonaka T, Hasegawa M, Bogoyevitch MA, Kanninen KM, Crouch PJ, White AR.

Mol Neurodegener. 2011 Aug 8;6:57. doi: 10.1186/1750-1326-6-57.

22.

PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site.

Haigh CL, Lewis VA, Vella LJ, Masters CL, Hill AF, Lawson VA, Collins SJ.

Cell Res. 2009 Sep;19(9):1062-78. doi: 10.1038/cr.2009.86. Epub 2009 Jul 14.

PMID:
19597535
23.

Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.

Lawson VA, Vella LJ, Stewart JD, Sharples RA, Klemm H, Machalek DM, Masters CL, Cappai R, Collins SJ, Hill AF.

Int J Biochem Cell Biol. 2008;40(12):2793-801. doi: 10.1016/j.biocel.2008.05.024. Epub 2008 Jun 11.

PMID:
18590830
24.

Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.

Vella LJ, Hill AF.

Methods Mol Biol. 2008;459:69-82. doi: 10.1007/978-1-59745-234-2_5.

PMID:
18576148
25.

Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid.

Vella LJ, Greenwood DL, Cappai R, Scheerlinck JP, Hill AF.

Vet Immunol Immunopathol. 2008 Aug 15;124(3-4):385-93. doi: 10.1016/j.vetimm.2008.04.002. Epub 2008 Apr 16.

PMID:
18501435
26.

Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes.

Sharples RA, Vella LJ, Nisbet RM, Naylor R, Perez K, Barnham KJ, Masters CL, Hill AF.

FASEB J. 2008 May;22(5):1469-78. doi: 10.1096/fj.07-9357com. Epub 2008 Jan 2.

PMID:
18171695
27.

The role of exosomes in the processing of proteins associated with neurodegenerative diseases.

Vella LJ, Sharples RA, Nisbet RM, Cappai R, Hill AF.

Eur Biophys J. 2008 Mar;37(3):323-32. Epub 2007 Dec 7. Review.

PMID:
18064447
28.

Packaging of prions into exosomes is associated with a novel pathway of PrP processing.

Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF.

J Pathol. 2007 Apr;211(5):582-90.

PMID:
17334982
29.

Alteration of the proline at position 7 of the HIV-1 spacer peptide p1 suppresses viral infectivity in a strain dependent manner.

Hill MK, Bellamy-McIntyre A, Vella LJ, Campbell SM, Marshall JA, Tachedjian G, Mak J.

Curr HIV Res. 2007 Jan;5(1):69-78.

PMID:
17266558

Supplemental Content

Loading ...
Support Center